chr15-34359248-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_153613.3(LPCAT4):āc.1454C>Gā(p.Thr485Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000212 in 1,563,688 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 32)
Exomes š: 0.00021 ( 2 hom. )
Consequence
LPCAT4
NM_153613.3 missense
NM_153613.3 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 5.21
Genes affected
LPCAT4 (HGNC:30059): (lysophosphatidylcholine acyltransferase 4) Members of the 1-acylglycerol-3-phosphate O-acyltransferase (EC 2.3.1.51) family, such as AGPAT7, catalyze the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA), a precursor in the biosynthesis of all glycerolipids. Both LPA and PA are involved in signal transduction (Ye et al., 2005 [PubMed 16243729]).[supplied by OMIM, May 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03060332).
BS2
High Homozygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPCAT4 | NM_153613.3 | c.1454C>G | p.Thr485Ser | missense_variant | 14/14 | ENST00000314891.11 | NP_705841.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPCAT4 | ENST00000314891.11 | c.1454C>G | p.Thr485Ser | missense_variant | 14/14 | 1 | NM_153613.3 | ENSP00000317300 | P1 | |
LPCAT4 | ENST00000563748.5 | n.1018C>G | non_coding_transcript_exon_variant | 5/5 | 2 | |||||
LPCAT4 | ENST00000567507.1 | c.*265C>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 3 | ENSP00000454422 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152090Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000260 AC: 44AN: 169062Hom.: 0 AF XY: 0.000370 AC XY: 33AN XY: 89138
GnomAD3 exomes
AF:
AC:
44
AN:
169062
Hom.:
AF XY:
AC XY:
33
AN XY:
89138
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000210 AC: 297AN: 1411480Hom.: 2 Cov.: 31 AF XY: 0.000260 AC XY: 181AN XY: 697414
GnomAD4 exome
AF:
AC:
297
AN:
1411480
Hom.:
Cov.:
31
AF XY:
AC XY:
181
AN XY:
697414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74426
GnomAD4 genome
AF:
AC:
34
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
20
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.1454C>G (p.T485S) alteration is located in exon 14 (coding exon 14) of the LPCAT4 gene. This alteration results from a C to G substitution at nucleotide position 1454, causing the threonine (T) at amino acid position 485 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Gain of ubiquitination at K481 (P = 0.0609);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at